If you’ve tested positive for COVID-19, you might be wondering if it’s necessary to take an antiviral medication, such as Paxlovid. Pfizer’s Paxlovid (nirmatrelvir and ritonavir) gained full approval ...

Six months after regulators issued an emergency use authorization for Paxlovid, physicians say they still have significant questions about prescribing guidelines for the leading treatment for ...

With COVID-19 cases again on the upswing, the antiviral Paxlovid has been slow to gain traction among patients and doctors even though the medication reduces hospitalizations and deaths. A recent ...

A review paper found several common heart medications have potential drug-drug interactions with Paxlovid, an antiviral commonly prescribed to patients with mild or moderate COVID-19, according to an ...

With COVID-19 infections becoming more common, experts have recently urged doctors to prescribe the antiviral drug Paxlovid more than they have been to minimize patients’ symptoms and reduce the ...

In a change of pace from the recent COVID-related business struggles for Pfizer, the drugmaker has picked up a valuable reward from the FDA in the form of a priority review voucher (PRV). The agency ...

The antiviral Paxlovid has changed the battle against COVID-19. It's so effective that more than 85% of people at risk for severe disease can avoid a bad outcome with a five-day course of the ...

Paxlovid (nirmatrelvir and ritonavir) was given emergency use authorization in December 2021, and that EUA was tweaked in February 2023 to allow providers to prescribe the drug to patients who do not ...

Paxlovid (Pfizer) is a combination of two oral antiviral medications: nirmatrelvir and ritonavir. Nirmatrelvir is a protease inhibitor that prevents viral replication. Ritonavir is used to boost the ...

WASHINGTON — Pfizer’s antiviral drug Paxlovid seems tailor-made for combatting Covid-19 in prisons: It doesn’t require an intravenous infusion like other treatments. There are signs it could ...

A covid pill could cut serious illnesses and help prevent the next pandemic. But it's expensive and in short supply. In the early days of the pandemic, all eyes were on potential vaccines. In May 2020 ...

As China’s struggles with covid treatment supply, frauds are running wild—targeting desperate people in search of medicine for themselves or their loved ones. China Report is MIT Technology Review’s ...